CN1418700A - Mayiniaotang pill for treating glucose in urine and preparation method thereof - Google Patents
Mayiniaotang pill for treating glucose in urine and preparation method thereof Download PDFInfo
- Publication number
- CN1418700A CN1418700A CN 02157912 CN02157912A CN1418700A CN 1418700 A CN1418700 A CN 1418700A CN 02157912 CN02157912 CN 02157912 CN 02157912 A CN02157912 A CN 02157912A CN 1418700 A CN1418700 A CN 1418700A
- Authority
- CN
- China
- Prior art keywords
- medical material
- radix
- weight
- rhizoma
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The Chinese medicine preparation ant sugar-reducing pill is made of 16 Chinese medicinal materials of ginseng, ant cicada molting, coptis orot, polygonatum root, cornus fruit, Chinese yam and others, and its production method includes the following steps: screening materials, mixing, drying, pulverizing, fully-mixing, sieving and taking powdered material below 100 meshes for stand-by; decocting medicinal material above 100 meshes at twice by adding water, filtering decoctions and mixing them, heating and concentrating the mixed medicine liquor, adding the above-mentioned powdered material, fully mixing and granulating, drying and filling so as to obtain the invented pill preparation which contains several trace elements of zinc and chromium, etc. and can be used for curing diabetes II type with high cure rate.
Description
Technical field
The invention belongs to Chinese herbal medicine, particularly relate to a kind of Formica fusca glucose in urine ball and processing method thereof.
Background technology
So far, medical circle does not still have final conclusion for the pathogenic factor of diabetes, and most scholars think viral infection institute extremely, and with energy and blood of human body two lose, suffer from a deficiency of the kidney and body in Xin, Chrome micronutrient levels deficiency relevant, cause the islet function imbalance, amount of insulin secretion reduces.
The common Chinese patent medicine that is used for treating diabetes at present has diabetes pill, YUQUAN WAN etc.Wherein diabetes pill is made up of flavor Chinese herbal medicine such as Radix Astragali, the Radix Rehmanniae, pollen; YUQUAN WAN is made up of flavor Chinese herbal medicine such as pollen, Radix Puerariae, Radix Ginseng, Radix Ophiopogonis, Fructus Mume, Poria, Radix Glycyrrhizae, Radix Astragali and Radix Astragali Mongolici (processed).Obviously there are not trace element such as Xin, Chrome in the prescription of above-mentioned common Chinese patent medicine, all uses pollen simultaneously.The viewpoint (667 pages) that the modern Chinese medicine pharmacology who publishes in June, 1999 according to Tianjin technology publishing house sets forth illustrates that pollen does not have blood sugar reducing function.
Summary of the invention
The present invention is in order to solve the technical problem that lacks trace element such as Xin, Chrome that the common Chinese patent medicine that is used for treating diabetes exists, and proposes the Formica fusca glucose in urine ball of trace element such as a kind of Xin of containing, Chrome.
Formica fusca glucose in urine ball of the present invention is made up of following component and parts by weight content thereof:
Radix Ginseng 20-30, Formica fusca 20-40, Cicadae moves back 20-30,
Rhizoma Coptidis 10-20, Rhizoma Polygonati 20-30, Fructus Corni 10-20,
Rhizoma Dioscoreae 10-20, Radix Astragali 10-30, Fructus Chaenomelis 10-20,
Radix Rehmanniae 10-20, Radix Notoginseng 10-20, Pollen Typhae 5-10,
Radix Aucklandiae 5-10, Rhizoma Atractylodis Macrocephalae 0-20, Radix Et Rhizoma Rhei 0-10,
Poria 0-20.
Its processing method of Formica fusca glucose in urine ball of the present invention is carried out according to following steps:
1, the medical material weighing and burden by ratio of weight and the number of copies after screening of respectively distinguishing the flavor of.
2, dry respectively, pulverize, fully mix back 100 mesh sieve sortings.
3, it is standby to get the following powdery medical material of 100 orders, and the following powdery medical material of 100 orders weight is half of batching gross weight at least.
4, the above graininess medical material of 100 orders decocts with water, medical material, water ratio 1: 5, and every decoction one time 30 minutes mixes behind twice, twice medical filtration totally.
5, mix back medicinal liquid heating and concentrate, treat that concentrated medicament weight is that a half of powdery medical material weight stops heating.
6, in concentrated medicament, add the abundant mixing granulation of powdery medical material.
7, packing according to quantity after the oven dry.
The basic role of each component of Formica fusca glucose in urine ball of the present invention is respectively:
Radix Ginseng: heart tonifying, blood sugar lowering.Formica fusca: have the outstanding role of regulating immunity, be rich in various trace elements such as zinc, per 100 gram Formica fuscas contain zinc 120-190 milligram, also contain aminoacid, protein, vitamin.Cicadae moves back: loose wind heat clearing away, convulsion calmness.Various trace elements such as Fu Han Chrome.Rhizoma Coptidis: anti-inflammation, blood sugar lowering.Rhizoma Polygonati: treatment coronary heart disease, blood sugar lowering.Fructus Corni: the temperature compensation Liver and kidney, hold back essence and blood.Rhizoma Dioscoreae: blood sugar lowering, raise immunity.The Radix Astragali: tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, anti-skin ulcer granulation promoting, diuretic detumescent.Fructus Chaenomelis: suppressing the hyperactive liver and easing the stomach, relaxing muscles and tendons and activating QI and blood in the collateral, invigorating the spleen for eliminating dampness.The Radix Rehmanniae: blood sugar lowering, hemostasis, heart tonifying.Radix Notoginseng: nourishing?, hemostasia and dissipation blood stasis, reducing swelling and alleviating pain.Pollen Typhae: contain various nutrients.The Radix Aucklandiae: promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, dampness diuretic.Radix Et Rhizoma Rhei: pathogenic fire purging relieving constipation, removing mass stagnate, clots absorbing blood.Poria: invigorating the spleen for eliminating dampness, tranquillizing and allaying excitement.
Beneficial effect of the present invention and advantage: the component Formica fusca of this Formica fusca glucose in urine ball contains zinc and other trace element, various trace elements such as Cicadae Tui Han Chrome, be combined with component Fructus Corni, Rhizoma Dioscoreae, the Rhizoma Polygonati of enriching yin and nourishing kidney, the component Radix Ginseng that tonifying QI to produce body fluid quenches the thirst, Radix Astragali Rhizoma Coptidis, the component Rhizoma Coptidis of anti-inflammation and the component Radix Notoginseng of blood circulation promoting and blood stasis dispelling, meet the main flow understanding of medical circle for the onset diabetes reason, start with to replenish Xin, Chrome trace element, the kidney invigorating void, QI and blood regulating have been received excellent curative.The incomplete statistics of this Formica fusca of root a tree name glucose in urine ball clinical trial data, the clinical treatment of accepting this Formica fusca glucose in urine ball of the type ii diabetes people of 126 blood glucose targets more than 14.3mmol/L is successively arranged in the year nearly, a 1-2 month blood glucose target reduced in the 6.2-7.3 scope after wherein 72 patients took according to quantity, get well after the after treatment, 43 patients take 1-2 month blood glucose target in back according to quantity has obvious decline near normal value.Only there are 11 patients to cut out because of the treatment of transferring from one hospital to another than severe complications.A blood glucose target adopts common Chinese patent medicine and other means Comprehensive Treatments at 9.2mmol/L and above diabetes patient thereof and accept for medical treatment the same period surplus in the of other 90, wherein type ii diabetes people's cure rate only is 12%, as seen this Formica fusca glucose in urine ball is higher to type ii diabetes people's cure rate, and effective percentage almost can reach absolutely.
Specific embodiment embodiment 1:
Calculate with every weight portion 0.1kg, Radix Ginseng 2.5kg, Formica fusca 3kg, the Cicadae of screening of learning from else's experience moves back 2.5kg, Rhizoma Coptidis 1kg, Rhizoma Polygonati 2.5kg, Fructus Corni 1.5kg, Rhizoma Dioscoreae 1.5kg, Radix Astragali 1.5kg, Fructus Chaenomelis 1.5kg, Radix Rehmanniae 1kg, Radix Notoginseng 1.5kg, Pollen Typhae 0.5kg, Radix Aucklandiae 0.5kg, Rhizoma Atractylodis Macrocephalae 1.5kg, Poria 1.5kg, altogether 24kg.Dry respectively, pulverize, fully mix back 100 mesh sieve sortings.It is standby to get the following powdery medical material of 100 orders 12kg.The above graininess medical material of 100 orders 12kg adds water 60kg and decocted according to a conventional method 30 minutes, and is standby behind the medical filtration.Medicinal residues continue to add water 60kg and decocted once more according to a conventional method 30 minutes, mix with standby medicinal liquid last time behind the medical filtration.It is that 6kg stops heating that mixing back medicinal liquid is heated to concentrated medicament, adds the powdery medical material and fully mix the back granulation in concentrated medicament, and the oven dry back is by every dress 6g packing, and furnace drying method and process conditions are same as prior art.
That the Formica fusca glucose in urine ball of present embodiment is applicable to is insufficiency of the spleen, the diarrhoea diabetics is taken every day three times, each one bag.
Embodiment 2:
Calculate with every weight portion 0.1kg, Radix Ginseng 2.5kg, Formica fusca 3kg, the Cicadae of screening of learning from else's experience moves back 2.5kg, Rhizoma Coptidis 1kg, Rhizoma Polygonati 2.5kg, Fructus Corni 1.5kg, Rhizoma Dioscoreae 1.5kg, Radix Astragali 1.5kg, Fructus Chaenomelis 1.5kg, Radix Rehmanniae 1kg, Radix Notoginseng 1.5kg, Pollen Typhae 0.5kg, Radix Aucklandiae 1kg, Radix Et Rhizoma Rhei 1.5kg, altogether 23kg.Dry respectively, pulverize, fully mix back 100 mesh sieve sortings.It is standby to get the following powdery medical material of 100 orders 11.5kg.The above graininess medical material of 100 orders 11.5kg adds water 57.5kg and decocted according to a conventional method 30 minutes, and is standby behind the medical filtration.Medicinal residues continue to add water 57.5kg and decocted once more according to a conventional method 30 minutes, mix with standby medicinal liquid last time behind the medical filtration.It is that 5.75kg stops heating that mixing back medicinal liquid is heated to concentrated medicament, adds the powdery medical material and fully mix the back granulation in concentrated medicament, and the oven dry back is by every dress 6g packing, and all the other are with embodiment 1.
The Formica fusca glucose in urine ball of present embodiment is applicable to that the diabetics of interior-heat caused by deficiency of YIN, constipation takes every day three times, each one bag.
Claims (2)
1, Formica fusca glucose in urine ball is characterized in that being made up of following component and parts by weight content thereof:
Radix Ginseng 20-30, Formica fusca 20-40, Cicadae moves back 20-30,
Rhizoma Coptidis 10-20, Rhizoma Polygonati 20-30, Fructus Corni 10-20,
Rhizoma Dioscoreae 10-20, Radix Astragali 10-30, Fructus Chaenomelis 10-20,
Radix Rehmanniae 10-20, Radix Notoginseng 10-20, Pollen Typhae 5-10,
Radix Aucklandiae 5-10, Rhizoma Atractylodis Macrocephalae 0-20, Radix Et Rhizoma Rhei 0-10,
Poria 0-20.
2, the processing method of Formica fusca glucose in urine ball is characterized in that it being to carry out according to following steps:
(1) the medical material weighing and burden by ratio of weight and the number of copies after screening of respectively distinguishing the flavor of.
(2) dry respectively, pulverize, fully mix back 100 mesh sieve sortings.
(3) it is standby to get the following powdery medical material of 100 orders, and the following powdery medical material of 100 orders weight is half of batching gross weight at least.
The above graininess medical material of (4) 100 orders decocts with water, medical material, water ratio 1: 5, and every decoction one time 30 minutes, totally twice, mix behind the medical filtration.
(5) mix back medicinal liquid heating and concentrate, treat that concentrated medicament weight is that a half of powdery medical material weight stops heating.
(6) in concentrated medicament, add the abundant mixing granulation of powdery medical material.
(7) packing according to quantity after the oven dry.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02157912 CN1263495C (en) | 2002-12-20 | 2002-12-20 | Mayiniaotang pill for treating glucose in urine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02157912 CN1263495C (en) | 2002-12-20 | 2002-12-20 | Mayiniaotang pill for treating glucose in urine and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1418700A true CN1418700A (en) | 2003-05-21 |
| CN1263495C CN1263495C (en) | 2006-07-12 |
Family
ID=4753011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02157912 Expired - Fee Related CN1263495C (en) | 2002-12-20 | 2002-12-20 | Mayiniaotang pill for treating glucose in urine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1263495C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391072B (en) * | 2007-09-21 | 2010-12-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic diarrhea |
| CN101530517B (en) * | 2008-03-12 | 2012-04-18 | 王文健 | Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| CN102432288A (en) * | 2011-09-16 | 2012-05-02 | 东南大学 | Preparation method of cracking-free lead lanthanum zirconate titanate film |
-
2002
- 2002-12-20 CN CN 02157912 patent/CN1263495C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391072B (en) * | 2007-09-21 | 2010-12-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic diarrhea |
| CN101530517B (en) * | 2008-03-12 | 2012-04-18 | 王文健 | Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| CN102432288A (en) * | 2011-09-16 | 2012-05-02 | 东南大学 | Preparation method of cracking-free lead lanthanum zirconate titanate film |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1263495C (en) | 2006-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1279946C (en) | Medicinal wine and its producing method | |
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN101204497A (en) | Peroral Chinese traditional medicine for aplastic anemia | |
| CN112717081B (en) | Blood-activating face-beautifying cream formula and application thereof | |
| CN1095672C (en) | Traditional Chinese medicine for treating cirrhosis and liver cancer | |
| CN1263495C (en) | Mayiniaotang pill for treating glucose in urine and preparation method thereof | |
| CN1053189A (en) | The preparation method of " promoting blood circulation and restoring paralysis pills " | |
| CN1101842A (en) | Health oral liquid for weight loss | |
| CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
| CN1879853A (en) | A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same | |
| CN1242775C (en) | Bushenshansong drink and preparation method thereof | |
| CN1077896A (en) | Medicine for psoriasis and manufacture method | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN1965962A (en) | Medicament for treating chronic nephritis and method for preparing same | |
| CN114344421A (en) | Medicinal and edible pure Chinese herbal medicine composition for treating hypertension and preparation method thereof | |
| CN113041324A (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof | |
| CN1386546A (en) | Capsule 'Yibao Yishou' for elongating life | |
| CN1170554C (en) | Help producing saliva and slaking thirst traditional Chinse medicine powder | |
| CN1127344C (en) | Oral pill for curing diabetes and its complication | |
| CN1117384A (en) | Traditional Chinese medicinal prescription (capsule series) for treating cardiovascular disease or cerebrovascular disease and method for mfg. same | |
| CN1911319A (en) | Decoction of herbal medicine for treating gynecologic amenorrhea, and its prepn. method | |
| CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |